Literature DB >> 30643250

Molecular landmarks of tumor hypoxia across cancer types.

Vinayak Bhandari1,2, Christianne Hoey1,3, Lydia Y Liu1,2, Emilie Lalonde1,2, Jessica Ray1,3, Julie Livingstone2, Robert Lesurf2, Yu-Jia Shiah2, Tina Vujcic3, Xiaoyong Huang3, Shadrielle M G Espiritu2, Lawrence E Heisler2, Fouad Yousif2, Vincent Huang2, Takafumi N Yamaguchi2, Cindy Q Yao2, Veronica Y Sabelnykova2, Michael Fraser2, Melvin L K Chua4,5, Theodorus van der Kwast6, Stanley K Liu1,3,7, Paul C Boutros8,9,10,11,12,13,14, Robert G Bristow15,16,17,18,19,20.   

Abstract

Many primary-tumor subregions have low levels of molecular oxygen, termed hypoxia. Hypoxic tumors are at elevated risk for local failure and distant metastasis, but the molecular hallmarks of tumor hypoxia remain poorly defined. To fill this gap, we quantified hypoxia in 8,006 tumors across 19 tumor types. In ten tumor types, hypoxia was associated with elevated genomic instability. In all 19 tumor types, hypoxic tumors exhibited characteristic driver-mutation signatures. We observed widespread hypoxia-associated dysregulation of microRNAs (miRNAs) across cancers and functionally validated miR-133a-3p as a hypoxia-modulated miRNA. In localized prostate cancer, hypoxia was associated with elevated rates of chromothripsis, allelic loss of PTEN and shorter telomeres. These associations are particularly enriched in polyclonal tumors, representing a constellation of features resembling tumor nimbosus, an aggressive cellular phenotype. Overall, this work establishes that tumor hypoxia may drive aggressive molecular features across cancers and shape the clinical trajectory of individual tumors.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30643250     DOI: 10.1038/s41588-018-0318-2

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  142 in total

1.  Schedule-dependent potentiation of chemotherapy drugs by the hypoxia-activated prodrug SN30000.

Authors:  Xinjian Mao; Sarah McManaway; Jagdish K Jaiswal; Cho R Hong; William R Wilson; Kevin O Hicks
Journal:  Cancer Biol Ther       Date:  2019-05-26       Impact factor: 4.742

Review 2.  Role of hyperoxic treatment in cancer.

Authors:  Sei W Kim; In K Kim; Sang H Lee
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-23

Review 3.  Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2019-07-30

4.  The Proteogenomic Landscape of Curable Prostate Cancer.

Authors:  Ankit Sinha; Vincent Huang; Julie Livingstone; Jenny Wang; Natalie S Fox; Natalie Kurganovs; Vladimir Ignatchenko; Katharina Fritsch; Nilgun Donmez; Lawrence E Heisler; Yu-Jia Shiah; Cindy Q Yao; Javier A Alfaro; Stas Volik; Anna Lapuk; Michael Fraser; Ken Kron; Alex Murison; Mathieu Lupien; Cenk Sahinalp; Colin C Collins; Bernard Tetu; Mehdi Masoomian; David M Berman; Theodorus van der Kwast; Robert G Bristow; Thomas Kislinger; Paul C Boutros
Journal:  Cancer Cell       Date:  2019-03-18       Impact factor: 31.743

Review 5.  Inside the hypoxic tumour: reprogramming of the DDR and radioresistance.

Authors:  Katheryn Begg; Mahvash Tavassoli
Journal:  Cell Death Discov       Date:  2020-08-18

6.  Pan-Cancer Survey of Tumor Mass Dormancy and Underlying Mutational Processes.

Authors:  Anna Julia Wiecek; Daniel Hadar Jacobson; Wojciech Lason; Maria Secrier
Journal:  Front Cell Dev Biol       Date:  2021-07-09

Review 7.  Impact of hypoxia on DNA repair and genome integrity.

Authors:  Alanna R Kaplan; Peter M Glazer
Journal:  Mutagenesis       Date:  2020-02-13       Impact factor: 3.000

8.  Integrated analysis of gene expression, alteration and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 1 in cancer.

Authors:  Chun-Yue Weng; Xin-Yi Hu; Ya-Jun Wang
Journal:  3 Biotech       Date:  2020-02-22       Impact factor: 2.406

9.  Distinct cell-types in the prostate share an aging signature suggestive of metabolic reprogramming.

Authors:  Preston D Crowell; Jenna M Giafaglione; Takao Hashimoto; Andrew S Goldstein
Journal:  Am J Clin Exp Urol       Date:  2020-08-15

10.  High-Resolution pO2 Imaging Improves Quantification of the Hypoxic Fraction in Tumors During Radiation Therapy.

Authors:  Xu Cao; Srinivasa Rao Allu; Shudong Jiang; Jason R Gunn Bs; Cuiping Yao PhD; Jing Xin PhD; Petr Bruza PhD; David J Gladstone ScD; Lesley A Jarvis Md PhD; Jie Tian PhD; Harold M Swartz Md Msph PhD; Sergei A Vinogradov PhD; Brian W Pogue PhD
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-09-28       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.